Director, Institute for Aging Research, Albert Einstein College of Medicine
“TAME will be the first trial to prove that aging itself can be targeted by a drug. Metformin is just the beginning.”
Director, Institute for Aging Research, Albert Einstein College of Medicine
“TAME will be the first trial to prove that aging itself can be targeted by a drug. Metformin is just the beginning.”
Join 12,000+ readers who get our free weekly digest of the latest longevity research, scientist interviews, and evidence-based insights.
Trusted by researchers, physicians & health enthusiasts
Free every Wednesday. Unsubscribe anytime.
🔒 We respect your privacy. Unsubscribe anytime.